Methylene blue acts as a potent nitric oxide synthase (NOS) inhibitor and guanylate cyclase inhibitor, which can help interrupt the pathological vasodilation and neurogenic inflammation associated with cluster headaches. By reducing nitric oxide production and cyclic guanosine monophosphate (cGMP) levels, it may modulate vascular tone and neurogenic pain pathways, potentially providing therapeutic relief for cluster headache patients.